Q2 Solutions understands that bringing a promising drug candidate to market requires a well-planned strategy that incorporates sensitive, specific, and validated assays to inform development decisions. As such, our highly trained scientists apply leading-edge technologies, automated platforms, and state-of-the-art techniques to support a wide range of bioanalytical services and ADME services.
From high-throughput ADME screening services and human clearance predictions to support drug metabolism and pharmacokinetics studies to drug-drug interaction testing and metabolite profiling to support clinical safety, the Q2 Solutions global network offers solutions to support every phase of drug discovery and development.
Our bioanalysis services include:
In addition to specific services detailed in the sections below, Q2 Solutions can provide bundled services for discovery and regulatory-phase packages to enable decision-making at each step of the development process.
Our new facility, in theworld-renowned Research Triangle Park, is the flagship laboratory for Q2 Solutions. This custom-designed, 160,000-square-foot facility houses a suite of scientific solutions...
Your clinical trial may involve samples from multiple sites to be tested by multiple laboratories. The data that flows from those tests may travel to multiple end users as well. Proper planning of...
In this episode, the second of a three-part series, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage...